Comment on GnRH analogue cotreatment with chemotherapy for preservation of ovarian function

Fertility and Sterility

Volumn 96, Issue 4, 2011, Pages

  Balkenende, Eva ^a   Dahhan, Taghride ^a   Van Der Veen, Fulco ^a   Goddijn, Mariëtte ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GONADORELIN;

BREAST CANCER; FEMALE FERTILITY; FOLLOW UP; HORMONAL THERAPY; HUMAN; LETTER; MENSTRUATION; OVARIAN PRESERVATION; OVULATION; PREMATURE OVARIAN FAILURE; PREMENOPAUSE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; NEOPLASMS; PREGNANCY; PRIMARY OVARIAN INSUFFICIENCY;

EID: 80053335273     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.07.1112     Document Type: Letter

References (6)

1. M.A. Bedaiwy, A.M. Abou-Setta, N. Desai, W. Hurd, D. Starks, and S.A. El-Nashar Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis Fertil Steril 95 2011 906 914
2. A. Badawy, A. Elnashar, M. El-Ashry, and M. Shahat Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study Fertil Steril 91 2009 694 697
3. K. Oktay, and M. Sonmezer Questioning GnRH analogs for gonadal protection in cancer patients Fertil Steril 92 2009 e32
4. F. Peccatori, and I. Demeestere GnRH analogue for chemotherapy-induced ovarian damage: too early to say? Fertil Steril 92 2009 e33
5. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 7414 2003 557 560 (Pubitemid 37088507)
6. B. Gerber, G. von Minckwitz, H. Stehle, T. Reimer, R. Felberbaum, and N. Maass Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study J Clin Oncol 29 2011 2334 2341